MyFinsight
Home
About
Contact
atra: the income statement
Download
Download image
Comprehensive income (loss)
-$4,301K
(80.34%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
$2K
(-94.44%↓ Y/Y)
Net income (loss)
-$4,303K
(80.36%↑ Y/Y)
Provision for (benefit
from) income taxes
$28K
(264.71%↑ Y/Y)
Income (loss) before
provision for (benefit...
-$4,275K
(80.50%↑ Y/Y)
Total other income
(expense), net
-$701K
(-314.79%↓ Y/Y)
Income (loss) from
operations
-$3,574K
(83.57%↑ Y/Y)
Other income
(expense), net
$4K
(-99.28%↓ Y/Y)
Interest income
$204K
(-55.56%↓ Y/Y)
Commercialization revenue
$3,453K
(-91.41%↓ Y/Y)
Interest expense
$909K
(-23.16%↓ Y/Y)
Total costs and
operating expenses
$7,027K
(-88.66%↓ Y/Y)
General and
administrative expenses
$3,987K
(-61.74%↓ Y/Y)
Research and development
expenses
$2,925K
(-93.34%↓ Y/Y)
Cost of
commercialization revenue
$115K
(-98.49%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)